1. Immunoterapia z użyciem przeciwciał monoklonalnych ukierunkowanych na szlak PD-1/PD-L1 w chorobach nowotworowych
   Aneta Malesa et al, 2018, Acta Haematologica Polonica CrossRef
2. Clinical implications of aberrant PD-1 expression for acute leukemia prognosis
   Yanjie Ruan et al, 2023, European Journal of Medical Research CrossRef
3. The effect of polymorphisms in PD-1 gene on the risk of epithelial ovarian cancer and patients' outcomes
   Yan Li et al, 2017, Gynecologic Oncology CrossRef
4. Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma
   Valli De Re et al, 2019, Frontiers in Microbiology CrossRef
5. Exploring the Bio-Functional Effect of Single Nucleotide Polymorphisms in the Promoter Region of the TNFSF4, CD28, and PDCD1 Genes
   Ding-Ping Chen et al, 2023, Journal of Clinical Medicine CrossRef
6. PDCD1 gene polymorphisms as regulators of T‐lymphocyte activity in cutaneous melanoma risk and prognosis
   Gabriela V. B. Gomez et al, 2018, Pigment Cell & Melanoma Research CrossRef
7. Programmed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control Studies
   Wenjing Dong et al, 2016, PLOS ONE CrossRef
8. Polymorphism of the programmed death‐ligand 1 gene is associated with its protein expression and prognosis in gastric cancer
   Yanhua Wu et al, 2019, Journal of Gastroenterology and Hepatology CrossRef
9. Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response
   Meghana Pagadala et al, 2023, Nature Communications CrossRef
10. PD-1 and cancer: molecular mechanisms and polymorphisms
    Arash Salmaninejad et al, 2018, Immunogenetics CrossRef
11. Immunopharmacogenomics in Cancer Management
    Gizem Calibasi-Kocal et al, 2018, Genetic Diversity and Disease Susceptibility CrossRef
12. Impact of PD-1 gene polymorphism and its interaction with tea drinking on susceptibility to tuberculosis
    Jing Wang et al, 2021, Epidemiology and Infection CrossRef
13. Immune Checkpoint Molecules—Inherited Variations as Markers for Cancer Risk
    Marta Wagner et al, 2021, Frontiers in Immunology CrossRef
14. Changes in plasma EBV-DNA and immune status in patients with nasopharyngeal carcinoma after treatment with intensity-modulated radiotherapy
    Qi Chen et al, 2019, Diagnostic Pathology CrossRef
15. Association of genetic polymorphisms in CD8 + T cell inhibitory genes and susceptibility to and progression of chronic HBV infection
    Hong Peng et al, 2015, Infection, Genetics and Evolution CrossRef
16. Increased PD-1 Level in Severe Cervical Injury Is Associated With the Rare Programmed Cell Death 1 (PDCD1) rs36084323 A Allele in a Dominant Model
    Mauro César da Silva et al, 2021, Frontiers in Cellular and Infection Microbiology CrossRef
17. PD1 gene polymorphism is associated with a poor prognosis in hepatocellular carcinoma following liver resection, cohort study
    Masateru Yamamoto et al, 2020, International Journal of Surgery CrossRef
18. The PD-1 rs36084323 A > G polymorphism decrease cancer risk in Asian: A meta-analysis
    Liang-Shan Da et al, 2018, Pathology - Research and Practice CrossRef